COMP <GO>
AAON vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
AAON Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AAON 5
— TMO 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: AAON
LAST: $67.40 (-10.49%) • MKT CAP: $6.21B
balance-sheet
6.82
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AAON VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AAON | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 26.70% | 41.00% | -14.30 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.50% | 9.30% | +0.20 | AAON | /roic <GO> |
| EV/EBITDA & P/E Valuation | 32.5x | 30.4x | +2.10 | TMO | /valuation <GO> |
| Free Cash Flow Yield | -1.04% | 2.40% | -3.44 | TMO | /fcf-yield <GO> |
| Operating Margin | 10.10% | 17.40% | -7.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 7.50% | 15.10% | -7.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 13.20% | 3.90% | +9.30 | AAON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.53% | 0.24% | +0.29 | AAON | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 6.82 | 4.50 | +2.32 | AAON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.8 | 59.1 | -24.39 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.94 | +0.07 | AAON | /macro-sensitivity <GO> |
| Forward P/E Multiple | 48.5x | 36.3x | +12.20 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.21B | $262.22B | -$256.01B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AAON REV | TMO REV | AAON GROSS % | TMO GROSS % | AAON FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.44B | $44.56B | 26.7% | 44.0% | -$64.4M | $6.29B |
| FY 2024 | $1.20B | $42.88B | 33.1% | 44.0% | $138.5M | $7.27B |
| FY 2023 | $0 | $42.86B | — | 44.0% | $158.9M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AAON // BETA 1.01
TMO // BETA 0.94